peptide therapeutics

Toronto, Canada | May 1, 2026 Apotex has received Health Canada approval for Apo-Semaglutide Injection™, a generic equivalent of...

CAMBRIDGE, Mass. & HOUSTON, April 9, 2026 Decoy Therapeutics, Inc. is rapidly gaining momentum as it enters a highly...

Vancouver, British Columbia — November 20, 2025 — PreveCeutical Medical Inc. has issued a formal clarification regarding its earlier...